An Unusual Case of Penile Prostate Cancer Uncovered by Multiparametric MRI and PSMA-Targeted 18F-DCFPyL PET/CT. (October 2017)

• Record Type: Journal Article
• Authors: Rowe, Steven P.; Gorin, Michael A.; Chu, Linda C.; Pienta, Kenneth J.; Pomper, Martin G.; Ross, Ashley E.; Macura, Katarzyna J.
• Is Part Of: Clinical nuclear medicine. Volume 42:Number 10(2017)
• Publication Date: 2017-10
• Subjects: DCFPyL -- prostate cancer -- prostate MRI -- PSMA; Nuclear medicine -- Periodicals; Radioisotope scanning -- Periodicals; Nuclear Medicine -- Periodicals; 616.07575
• DOI: 10.1097/RLU.0000000000001785
• Languages: English
• ISSNs: 0363-9762

Abstract

Abstract : Abstract: Multiparametric MRI (mpMRI) is currently the test of choice for imaging sites of prostate cancer located within the pelvis. However, molecular imaging with PET radiotracers that bind to prostate-specific membrane antigen is increasingly being used for this purpose and may compliment mpMRI findings. We present a case of a 59-year-old man with elevated postprostatectomy serum prostate-specific antigen level who was found on both mpMRI and prostate-specific membrane antigen–targeted PET to harbor residual prostate cancer in the corpus spongiosum along the proximal urethra.